Balchem Reports First Quarter 2025 Financial Results

Montvale, NJ, April 24, 2025 – Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2025 fiscal first quarter ended March 31, 2025. For the quarter, the Company reported net sales of $250.5 million, net earnings of $37.1 million, adjusted EBITDA^(a) of $66.3 million, and free cash flow^(a) of $31.0 million.

First Quarter 2025 Financial Highlights:

• Record net sales of $250.5 million, an increase of $10.9 million, or 5%, compared to the prior year quarter.
• GAAP net earnings were $37.1 million, an increase of 27.8%, from the prior year quarter.
• Record Adjusted EBITDA was $66.3 million, an increase of 8.9%, from the prior year quarter.
• GAAP earnings per share of $1.13 compared to $0.89 in the prior year quarter and adjusted earnings per share^(a) of $1.22 compared to $1.03 in the prior year quarter.
• Cash flows from operations were $36.5 million, with free cash flow^(a) of $31.0 million.
• Sales and earnings from operations growth in all three of our segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

Recent Highlights:

• In the first quarter, we launched Balchem’s new corporate website. This innovative platform enhances user experience and provides comprehensive insights into our products and innovations. The new site features improved navigation, detailed product information, and resources for all stakeholders, including investors, customers, and employees. Additionally, we have introduced new product brand sites for Albion^® Minerals, K2VITAL^™, Optifolin+^®, OptiMSM^®, and VitaCholine^®, which have an increased end-consumer orientation to aid in our efforts to build awareness and drive market penetration.
• On April 22, we released our 2024 Sustainability Report, highlighting our sustainability initiatives and accomplishments. Guided by our core values and our vision of making the world a healthier place, our Sustainability Report demonstrates our commitment to bringing innovative solutions for global health and nutrition needs, and to operate with excellence as strong stewards of our employees, customers, shareholders, and communities.

_{(a) See “Non-GAAP Financial Information” for reconciliations of GAAP and non-GAAP financial measures.}

Quarterly Conference Call

A quarterly conference call will be held on Thursday, April 24, 2025, at 11:00 AM Eastern Time (ET) to review first quarter 2025 results. Ted Harris, Chairman, President and CEO and Martin Bengtsson, CFO will host the call. We invite you to listen to the conference by calling toll-free 1-877-407-8289 (local dial-in 1-201-689-8341), five minutes prior to the scheduled start time of the conference call. The conference call will be available for replay three hours after the conclusion of the call through end of day Thursday, May 8, 2025. To access the replay of the conference call, dial 1-877-660-6853 (local dial-in 1-201-612-7415), and use conference ID #13753034.